Mary Tagliaferri

Mary Tagliaferri is a declared insider at 3 companies (board member); the most frequent names are Bionovo Inc, Enzo Biochem Inc and Y-mAbs Therapeutics, Inc. Between 26 January 2006 and 11 June 2024, the trades on record add up to 20 filings.

On the open market, the record shows 1 purchase worth €7,038 and 3 sales worth €315k. Netting one side against the other leaves €308k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 6 share grants.

Most recently, on 13 June 2024, the filings show a share grant in Y-mAbs Therapeutics, Inc. The last purchase on record was published on 23 February 2010, which is 6,087 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.